Company Description
Keryx Biopharmaceuticals, Inc.. The Group's principal activities are to acquire, develop and market novel pharmaceutical products for the treatment of life-threatening diseases including diabetes and cancer. It has a product candidate SulonexT82 ...
More
Related Business Topics
Breaking News
Reuters - Nov. 11, 2009, 6:42 AM
CNBC - Nov. 11, 2009, 5:47 AM
CNBC - Nov. 11, 2009, 5:47 AM
Reuters - Nov. 11, 2009, 5:44 AM
CNBC - Nov. 9, 2009, 2:32 PM
